BioMed Realty, a Blackstone portfolio company specializing in real estate solutions for the life science and technology sectors, has announced today the signing of a new lease with Curi Bio, a developer of human stem cell-based platforms for drug discovery. The seven-year lease encompasses 13,942 square feet at 201 Elliott Avenue West, located in Seattle’s […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
A small industrial building with yard storage on Tualatin's Highway 99W sold...
ByThe RegistryOctober 24, 2026Westside Behavior Therapy pays $4.1 million, or $227.78 per square foot, to...
ByThe RegistryOctober 24, 2026The auto parts chain's 8,878-square-foot deal at a late-1960s strip center on...
ByThe RegistryOctober 24, 2026Los Angeles athleisure brand Alo Yoga has filed plans to convert the...
ByThe RegistryOctober 24, 2026